Literature DB >> 12737802

FapR, a bacterial transcription factor involved in global regulation of membrane lipid biosynthesis.

Gustavo E Schujman1, Luciana Paoletti, Alan D Grossman, Diego de Mendoza.   

Abstract

Bacterial cells exert exquisite control over the biosynthesis of their membrane lipids, but the mechanisms are obscure. We describe the identification and purification from Bacillus subtilis of a transcription factor, FapR, that controls the expression of many genes involved in fatty acid and phospholipid metabolism (the fap regulon). Expression of this fap regulon is influenced by antibiotics that specifically inhibit the fatty acid biosynthetic pathway. We show that FapR negatively regulates fap expression and that the effects of antibiotics on fap expression are mediated by FapR. We further show that decreasing the cellular levels of malonyl-CoA, an essential molecule for fatty acid elongation, inhibits expression of the fap regulon and that this effect is FapR dependent. Our results indicate that control of FapR by the cellular pools of malonyl-CoA provides a mechanism for sensing the status of fatty acid biosynthesis and to adjust the expression of the fap regulon accordingly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737802     DOI: 10.1016/s1534-5807(03)00123-0

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  65 in total

Review 1.  Functional genomics of gram-positive microorganisms.

Authors:  Marta Perego; James A Hoch; John F Barrett
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

2.  Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

Authors:  Bernd Hutter; Christoph Schaab; Sebastian Albrecht; Matthias Borgmann; Nina A Brunner; Christoph Freiberg; Karl Ziegelbauer; Charles O Rock; Igor Ivanov; Hannes Loferer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Development of a Genetically Encoded Biosensor for Detection of Polyketide Synthase Extender Units in Escherichia coli.

Authors:  Edward Kalkreuter; Aaron M Keeler; Alexandra A Malico; Kyle S Bingham; Anuran K Gayen; Gavin J Williams
Journal:  ACS Synth Biol       Date:  2019-05-28       Impact factor: 5.110

4.  Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants.

Authors:  C Freiberg; H P Fischer; N A Brunner
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  The hotdog thioesterase EntH (YbdB) plays a role in vivo in optimal enterobactin biosynthesis by interacting with the ArCP domain of EntB.

Authors:  Damien Leduc; Aurélia Battesti; Emmanuelle Bouveret
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

6.  Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).

Authors:  Jiangwei Yao; John B Maxwell; Charles O Rock
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

Review 7.  Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?

Authors:  Joshua B Parsons; Charles O Rock
Journal:  Curr Opin Microbiol       Date:  2011-08-20       Impact factor: 7.934

Review 8.  How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

9.  Transcriptome analysis of sorbic acid-stressed Bacillus subtilis reveals a nutrient limitation response and indicates plasma membrane remodeling.

Authors:  Alex Ter Beek; Bart J F Keijser; Andre Boorsma; Anna Zakrzewska; Rick Orij; Gertien J Smits; Stanley Brul
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

10.  Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition.

Authors:  Letal I Salzberg; John D Helmann
Journal:  J Bacteriol       Date:  2008-09-26       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.